INTRODUCTION
============

As a result of the dramatic increase in microbial infections, serious attention has been directed in recent years towards the discovery and development of new antimicrobial drugs.

In medicinal chemistry, thiophene derivatives have been well known for their therapeutic applications. A review of the recent literature showed that many effective antimicrobial agents contain an heterocyclic moiety within their structure \[[@R1], [@R2]\] with special emphasis on those agents incorporating a thiophene moiety \[[@R3]-[@R7]\]. The thiophene ring system is notably a structural component of the commercial imidazole antifungal agent sertaconazole \[[@R8]\]. In addition, the antimicrobial profile of condensed thiophenes, particularly their thieno\[2,3-d\]pyrimidin-4-one analogues, is also well categorized in the literature \[[@R9]-[@R11]\].

Coumarin and its derivatives represent one of the most active classes of compounds possessing a wide spectrum of biological activity \[[@R12]-[@R18]\]. The interesting biological activity of these coumarins made these compounds attractive targets in organic synthesis.

Azo compounds constitute one of the largest classes of industrially synthesized organic compounds, potent in drug and cosmetics \[[@R19]\]. Azo dyes are used widely in dying textile fibers, biomedical studies, advanced applications in organic synthesis and high technological areas like lasers, liquid crystalline displays, electro-optical devices and ink jet printer \[[@R20]-[@R22]\] as well as shows variety of interesting biological activities including antibacterial \[[@R23]-[@R26]\] and pesticidal activities \[[@R27]\]. The azo dyes possess antiseptic and antiprotozoal properties and also promote wound healing.

Based on the above considerations, we investigated the synthesis of hybrid molecular architectures containing thiophene, coumarin, and azo moieties likely to combine the biological features of all the components.

RESULTS AND DISCUSSION
======================

Chemistry
---------

The starting 2-aminothiophene reagent **4** was prepared by applying the third version of the Gewald methodology \[[@R28], [@R29]\], whereby the first step of the procedure consisted of a Knoevenagel \[[@R30]\] condensation of 2-hydroxy-1-acetonaphthon (**1**) with ethyl cyanoacetate (**2**) to give the fused benzocoumarin **3** (Scheme **[1](#S1){ref-type="scheme"}**). In the second step of the reaction sequence, compound **3** was treated with elemental sulphur and ammonia as catalytic amine base to afford compound **4** in excellent yield as previously reported \[31\]. The melting point, as well as all the elemental and all the other spectroscopic data were in all respects comparable to those originally reported for this compound.

The *in situ* formed intermediate thienyl diazonium sulphate **5** (Scheme **[2](#S2){ref-type="scheme"}**) was generated from the diazotization of compound **4** using nitrosyl sulphuric acid at very low temperature (0-5 °C). The freshly prepared diazonium solution was then coupled with 2-aminothiophene **4**. The resulted mixtures were worked-up as usual to yield the azo compound **6** (Scheme **[2](#S2){ref-type="scheme"}**), which was fully characterized by its physical, elemental and spectroscopic data.

Compound **6** was obtained as green yellowish powder with a sharp melting point at 213.5 ^0^C. Its UV-visible spectrum recorded in DMSO, showed absorptions in the range 212-500 nm, in agreement with the highly conjugated (18π)-electrons of the heteroaromatic chain, partly extended to the three annelated benzene rings. This also justified the strong bathochromic effect of the main absorption bands from the starting 2-aminothiophene compound **4** into the final product **6**.

On the IR-spectrum, the Csp^2^-H stretching frequencies due to the aromatic rings were observed around 2950 cm^-1^, whereas the combined strong absorption frequencies of the C=O groups was exhibited around 1724 cm^-1^. Strong to medium size stretching frequencies of the benzenic and thiophenic C=C bonds were exhibited at 1677 and 1588 cm^-1^, and in the range 1544-1500 cm^-1^ respectively. The *ortho* disubstitution pattern of the benzene rings was characterized by the strong absorption band appearing at 767cm^-1^. The presence of the --N=N-- bonds was confirmed by a medium size band at 1490 cm^-1^.

The structure of compound **6** is further strongly supported by its HRMS ESI^+^-mode, which shows the pseudo molecular ion peak at m/z 685 (29%) corresponding to \[M+H\]; this is in full agreement with the combustion analysis data. The mass spectrum of compound **6** contained fragments ions at m/z 640 (3%), 596 (1%), 552 (3%), 659 (8%), 627 (1%), 620 (1%), 588 (1%), 532 (1%), 628 (1%), 600 (1%), 572 (2%), 544 (1%), 516 (40%), 484 (1%), 452 (1%) and 248 (94%) which could be assigned to \[M^+^ -CO~2~\], \[M^+^ -2CO~2~\], \[M^+^ -3CO~2~\], \[M^+^ -N~2~\], \[M^+^ -2N~2~\], \[M^+^ -2S\], \[M^+^ -3S\], \[M^+^ -3S -2N~2~\], \[M^+^ -2CO\], \[M^+^ -3CO\], \[M^+^ -3CO -N~2~\], \[M^+^ -3CO -2N~2~\], \[M^+^ -3CO -3N~2~\], \[M^+^ -3CO -3N~2~-S\], \[M^+^ -3CO -3N~2~ -2S\] and \[M^+^ -3CO -3N~2~ -3S -C~10~H~4~\]. The Scheme **[3](#S3){ref-type="scheme"}** below rationalizes the formation of the fragments at *m/z* 516 (40%), 437 (65%), 393 (19%) and 339 (42%) respectively.

The absence of thiophenic protons in the ^1^H-NMR spectrum of compound **6** which normally appear in the range 6.5-7.2 ppm, indicated that these protons were involved in the cyclisation process. The ^1^H-NMR spectrum showed four sets of aromatic Csp^2^-H protons at 8.73 (dd; *J* = 8; 1.6 Hz; H-7, H-21 et H-35), 7.85 (ddd; *J* = 8.4; 6.4; 1.6 Hz; H-9, H-23 et H-37), 7.53 (dd; *J* = 5.2; 1.2 Hz; H-10, H-24 et H-38) and 7.51 ppm (ddd; *J* = 8.1; 7.2; 1.2 Hz; H-8, H-22 et H-36). The presence of the signal of four protons instead of twelve could be explained by the symmetric nature of compound **6**.

The ^13^C-NMR spectrum of compound **6** exhibited eleven signals instead of thirty three as deduced from the molecular formula. The symmetrical nature of compound **6** could also explain this observation. The ^13^C-NMR spectrum consisted of 11 signals among which four \[135.5 (C-9, C-23 and C-37); 128.9 (C-7, C-21 and C-35); 125.4 (C-8, C-22 and C-36) and 117.1 (C-10, C-24 and C-38)\] could be assigned to tertiary Csp^2^-H aromatic carbons. The remaining other seven signals \[184.9 (C-13, C-27 and C-41); 154.9 (C-11, C-25 and C-39); 153.7 (C-5, C-19 and C-33); 153.5 (C-14, C-28 and C-42); 147.8 (C-1 ; C-15 and C-29); 119.9 (C-6, C-20 and C-34) and 114.9 (C-4, C-18 and C-32)\] were attributed to the quaternary carbon atoms by comparing the experimental values with the simulated ones.

A remarkable feature in the ^13^C-NMR spectrum of this compound is the intense downfield shifts (Δδ = 19.2 ppm) of the δ~C=O~ of the carbonyl of the coumarin rings respectively from 165.70 ppm in the parent thiophene substrate **4** \[31\] to 184.9 ppm in the coupling product. This abnormally high value could be explained by the strong diamagnetic anisotropy \[[@R33], [@R34]\] of the 18 π-electrons of the heteroaromatic ring system comprising the alternating three fused thiophene rings and the alternating three --N=N-- bonds.

It should be mentioned that, in cyclic conjugated systems such as annulenes, the effect of ring currents is particularly illustrative. In fact, with (4n+2) π-electrons the annulenes exhibit aromatic character. For example (18)-annulene \[[@R33], [@R34]\] exhibits a similar ring current as found in six membered aromatic or heteroaromatic compounds. In these cases too, the magnetic field induced by the circulation of π-electrons opposes the applied magnetic field in the center of the ring and reinforces it around the periphery. As a result, the protons and carbons lying inside the ring of (18)-annulenes are strongly shielded while those on the outer side are strongly deshielded. In the case of compound **6**, the 18-membered heteroaromatic skeleton is planar and is assumed to have a similar behavior in the applied magnetic field as with normal (18)-annulenes.

The HMBC spectra \[[@R35], [@R36]\] were very helpful for locating the tertiary and quaternary carbons by identifying the various protons interacting with them through two-bond (^2^*J*~CH~), three-bond (^3^*J*~CH~) and occasionally four-bond (^4^*J*~CH~) couplings as displayed in Table **[1](#T1){ref-type="table"}** and Fig. (**[1](#F1){ref-type="fig"}**). Additionally, the HSQC experiments were performed in order to assign accurately the direct connectivities of the aromatic sp2 carbons to the corresponding protons.

Biology
-------

### Antimicrobial Activity

The results of the antimicrobial activity are summarized in Table **[2](#T2){ref-type="table"}**. Compounds **4** and **6** displayed weak to moderate antibacterial and antifungal activities (MIC = 16--64 μg/ml). Compounds **4** and **6** were respectively the most active compounds against bacteria (MIC = 32--64 μg/ml) and yeasts (MIC = 16--64 μg/ml). No activity was noticed for compound **3** against all the tested microorganisms (results not shown). Previous studies have shown antibacterial \[[@R37]\] and antifungal \[[@R38]\] activities of azo compounds. The lowest MIC value of 16 μg/mL was recorded on *Candida albicans* with compound **4** while the lowest MBC value of 32 μg/mL was obtained on *Shigella flexneri* and *Escherichia coli* with compound **6** and on *Candida albicans* and *Candida parapsilosis* with compound **4**. However, the highest MIC and MMC values of 128 μg/mL were recorded on *Candida glabrata* with compound **6**. A lower MMC/MIC (≤4) value signifies that a minimum amount of compound is used to kill the microbial species, whereas, a higher MMC/MIC (\>4) value signifies the use of comparatively more amount of sample for the control of any microorganism \[[@R38]\]. The findings of the present study suggest that compounds **4** and **6** possess microbicidal activity against the sensitive microorganisms.

### Ferric Reducing Antioxidant Power (FRAP)

The FRAP assay measures the ability of an antioxidant to reduce ferric (III) to ferrous (II) in a redox-linked colourimetric reaction that involves single electron transfer \[[@R40]\]. The reducing power of a compound serves as a significant indicator of its potential antioxidant activity. The results of the reducing power assay of synthesized compounds are summarized in Fig. (**[2](#F2){ref-type="fig"}**). All the investigated compounds showed dose-dependent reducing power. Interestingly, compound **4** showed the lowest reducing power, while compound **6** exhibited the highest reducing power at the different concentrations tested. The antioxidant power of compound **6** is almost equal to that of butylated hydroxytoluene (BHT) used as standard antioxidant.

### DPPH Free Radical Scavenging Activity

The concentrations which decreased by 50% the absorbance of DPPH (EC~50~) are presented in Fig. (**[3](#F3){ref-type="fig"}**). These results showed that the compound **4** had the highest EC~50~ (*i.e.,* the lowest activity) while compound **6** had the lowest EC~50~ (*i.e.* had the highest activity). The DPPH free radical scavenging activity of compound **6** was comparable to that of the standard antioxidant vitamin C. These results corroborate the FRAP assay, where this compound exhibited the best antioxidant activity. Previous study has shown strong antioxidant activity of azo compounds performed by using DPPH free radical scavenging assay and metal chelating method \[[@R41]\]. The results of the antioxidant study show that these azo compounds may have great relevance in the prevention and therapies of diseases in which oxidants or free radicals are implicated \[[@R41]\].

From the structure activity relationship (SAR) point of view, one can logically say that, the thiolation of the carbonitrile **3** at its methyl group, followed by the intramolecular heterocyclisation and aromatization of the fused five member ring to afford compound **4** -- resulted into the significant improvement of the antibacterial and antifungal activities of the latter as compared to its precursor. However, these chemical transformations have slightly reduced the antioxidant activity of **4** compare to that of compound **3**.

Furthermore, the diazotization of compound **4**, which led to the homocyclotrimerization of the *in situ* formed thienyl diazonium salts **5**, resulted in enhancing significantly and globally the evaluated biological activities of the final product **6**. The results are in accordance with other reports in the literature \[[@R42], [@R43]\], which showed the importance of thiolation and diazotization in antimicrobial and antioxidant activities.

MATERIALS AND METHODS
=====================

General Information
-------------------

All Melting points are corrected and were determined with a STUART SCIENTIFIC Melting Point Apparatus Model SMP3. The TLCs were carried out on Eastman Chromatogram Silica Gel Sheets (13181; 6060) with fluorescent indicator. A mixture of ethyl acetate and methylene chloride (1:1) was used as eluent and iodine was used as revelator for the chromatograms. The IR spectra were measured with a Fourier Transform Infrared spectrometer Brucker Alpha. The UV spectra were recorded with a JENWAY 6715 UV-Vis Spectrophotometer. Combustion analyses were carried out with a C, H, N, S Euro EA from Hekatech company, their results were found to be in good agreement (±0.3%) with the calculated values. EIMS spectra were recorded on a double focusing mass spectrometer (Varian MAT 311A). ^1^H-NMR spectra were recorded in DMSO-d~6~ on a Bruker DRX spectrometer operating at 500 MHz. ^13^C-NMR spectra were recorded in DMSO-d~6~ on a Bruker DRX spectrometer operating at 125 MHz. TMS was used as internal reference.

Preparation of the Reagents and Starting Materials
--------------------------------------------------

All the reagents mentioned in this work were purchased from Aldrich and Fluka and were used without further purification. Starting material **4** has been prepared according to literature procedures as published earlier \[[@R31]\].

3-Amino-4H-thieno \[3,4-c\] \[[@R1]\] Benzopyran-4-one (4)
----------------------------------------------------------

A mixture of 2-ceto-4-methyl-2H- \[[@R1]\] benzopyran-3-carbonitrile (4.65 g) and sulphur (1.22 g, in excess) in ethanol (30 ml) was stirred using a magnetic plate shaker thermostated at 45 °C. Ammonia (6 ml) was added drop wise during the first 10 min of the reaction. After 7 h of reaction, the resulting precipitate (5.08 g, 93%) was collected by filtration, washed with distilled water and recrystallised in benzene to yield a yellow powder, mp 195--196 °C (Lit.18 198--199 °C, from benzene); IR (potassium bromide): 3449 (-NH2); 1687 (C=O); 1603 and 1547 (C=C); 1224 (C-O); 1H NMR: 7.87 (1H; dd; J = 8.0; 1.5 Hz; H-8); 7.36 (1H; ddd; J = 8.0; 7.4; 1.8 Hz; H-6); 7.22-7.17 (2H; m; H-7 and H-5); 7.78 (2H; br s; NH2); 6.89 (1H; s; thiophenic H); 13C(1H) NMR: 158.98 (C-2); 118.05 (C-2a); 166.70 (C-3); 151 (C-4a); 97.54 (C-5); 124.39 (C-6); 117.09 (C-7); 123.91 (C-8); 130.90 (C-8a); 98.07 (C-8b); 129.26 (C-9); ms: (EI) m ⁄ z (%) 217 (M+; 100%). Anal. Calcd for C~11~H~7~NO~2~S C: 60.83; H, 3.23; N, 6.45; S, 14.75. Found C, 61.17; H, 3.36; N, 6.49; S, 14.45.

Preparation of Diazonium Salt Solution
--------------------------------------

Dry sodium nitrite (2.07 g, 3 mmol) was slowly added over a period of 30 minutes to concentrated sulphuric acid (10 mL) with occasional stirring. The solution was cooled to 0-5 °C. Compound **4** (0.22 g, 1 mmol) was dissolved in DMSO (10 mL) and cooled to 0-5 °C. The nitrosyl sulphuric acid solution was added to the solution of **4** and the temperature was maintained to 0-5 °C. The clear diazonium salt solution thus obtained consisting of the *in situ* formed intermediates **5**, was used immediately in the coupling reactions.

Procedure for the Preparation of the Coupling Product 6
-------------------------------------------------------

Aniline (0.279 g; 3 mmol) was dissolved in DMSO (10 mL) and then cooled in an ice-bath at 0-5 °C. The diazonium solution of **4** previously prepared was added drop wise over 1 hour, and then 15 mL of sodium acetate solution (10%) was added in the mixture. The solid precipitate consisting of the previously reported \[[@R32]\] (4H)-2-(p-Aminophenylazo)thieno\[3,4-c\]chromen-4-one hydrogen sulfate (**7**) was collected on a filter and crystallised from methanol to give the corresponding thienyl azo aryl dye. Work up of the resulted filtrate gave compound **6** in average yield of 11%.

12,26,40-trioxa-43,44,45-trithia-2,3,16,17,30,31-hexaazadecacyclo \[30.10.1.1^4,15^.1^18,29^.0^5,14^. 0^6,11^.0^19,28^.0^20,25^.0^33,42^.0^34,39^\] pentatetraconta-1(42),2,4,6,8,10,14,16,18,20,22,24,28,30,32, 34, 36,38-octadecaene-13,27,41-trione (6).

Compound **6** (124 mg, 11%) was obtained as green yellowish powder. m.p. 213.5 °C; Rf = 0.43 in CH~2~Cl~2~/AcOEt 50% v/v; IR (potassium bromide): 2588 (=C-H), 1724 (C=O), 1677-1588 (C~Ar~=C~Ar~), 1544-1500 (thiophenic C=C), 1490 (-N=N-), 767 (=C~Ar~-H) cm^−1^; λmax (DMSO) (Log ε): 400 (4.70), 282 (4.49), 229 (4.71); ^1^H-NMR (DMSO-d~6~, 500 MHz) *δ* 8.73 (dd, 3H, 7- H, 21-H and 35-H, *J* = 8 and 1.6 Hz), 7.85 (ddd, 3H, 9-H, 23-H and 37-H, *J* = 8.4, 6.4 and 1.6 Hz), 7.53 (dd, 3H, 10-H, 24-H and 38-H, *J* = 5.2 and 1.2 Hz), 7.51 (ddd, 3H, 8-H, 22-H and 36-H, *J* = 8.1, 7.2 and 1.2 Hz). ^13^C (^1^H)- NMR (DMSO-d~6~, 125 MHz) *δ* 135.5 (C-9, C-23 and C-37), 128.9 (C-7, C-21 and C-35), 125.4 (C-8, C-22 and C-36), 117.1 (C-10, C-24 and C-38), 184.9 (C-13, C-27 and C-41), 153.7 (C-5, C-19 and C-33), 153.5 (C-14, C-28 and C-42), 147.8 (C-1, C-15 and C-29), 119.9 (C-6, C-20 and C-34), 114.9 (C-4, C-18 and C-32), 154.9 (C-11, C-25 and C-39); ms: (ESI^+^) *m/z* (%) 685 (29), 516 (40), 437 (65), 393 (19), 339 (42), 248 (94). Anal. Calcd. for C~33~H~12~N~6~O~6~S~3~: C, 57.89; H, 1.77; N, 12.27; S, 14.05. Found C, 57.82; H, 1.75; N, 12.30; S, 14.11.

BIOLOGICAL ASSAY
================

Microorganisms
--------------

The studied microorganisms were reference strains (from the ATCC) of *Salmonella typhi* ATCC6539, *Enterococcus faecalis* ATCC10541, *Escherichia coli* ATCC11775, *Klebsiella pneumoniae* ATCC13883, *Candida parapsilosis ATCC 22019*, *C. albicans* ATCC 9002. Also, included were four clinical isolates of *Shigella flexneri*, *Salmonella paratyphi* B, *Salmonella paratyphi* A, and *Candida parapsilosis collected* from Pasteur Centre (Yaounde-Cameroon) and one clinical strain of *Candida glabrata* IP35 obtained from Pasteur Institute (Paris-France). The bacterial and fungal species were maintained on agar slant at +4 °C and subcultured at 37 °C on nutrient agar (NA, Conda, Madrid, Spain) and Sabouraud Dextrose Agar (SDA, Conda) slants respectively, prior to any antimicrobial test.

Determination of Minimum Inhibitory Concentration (MIC) and Minimum Microbicidal Concentration (MMC)
----------------------------------------------------------------------------------------------------

MIC values were determined by a broth micro-dilution method as described earlier \[[@R44]\] with slight modifications. Each test sample was dissolved in dimethylsulfoxide (DMSO) and the solution was then added to Mueller Hinton Broth (MHB) for bacteria or Sabouraud Dextrose Broth (SDB) for yeasts to give a final concentration of 1024 μg/mL. This was serially diluted twofold to obtain a concentration range of 0.25 - 1024 μg/mL. Then, 100 μL of each concentration were added in each well (96-well microplate) containing 95 μL of MHB or SDB and 5 μL of inoculum for final concentrations varying from 0.25--512 μg/mL. The inoculum was standardized at 1.5×10^6^ CFU/mL by adjusting the optical density to 0.1 at 600 nm using a JENWAY 6105 UV/Vis spectrophotometer. The final concentration of DMSO in each well was \< 1% \[preliminary analyses with 1% (v/v) DMSO did not inhibit the growth of the test organisms\]. The negative control well consisted of 195 μL of MHB or SDB and 5 μL of the standard inoculum. The plates were covered with sterile lids, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 24 h (for bacteria) or for 48 h (for yeasts). The assay was repeated three times. The MIC values of samples were determined by adding 50 μL of a 0.2 mg/mL *p*-iodonitrotetrazolium violet solution followed by incubation at 37 °C for 30 min. Viable microorganisms reduced the yellow dye to a pink color. MIC values were defined as the lowest sample concentrations that prevented this change in color indicating a complete inhibition of microbial growth. For the determination of MMC values, a portion of liquid (5 μL) from each well that showed no growth of microorganism was plated on Mueller Hinton Agar or SDA and incubated at 37 °C for 24 h (for bacteria) or 37 °C for 48 h (for yeasts). The lowest concentrations that yielded no growth after this subculturing were taken as the MMC values \[[@R45]\]. Ciprofloxacin (Sigma-Aldrich, Steinheim, Germany) and nystatin (Merck, Darmstadt, Germany) were used as positive controls for bacteria and yeasts, respectively.

Ferric Reducing Antioxidant Power (FRAP) Assay
----------------------------------------------

The ferric reducing power was determined by the Fe^3+^-Fe^2+^ transformation in the presence of of compounds **3**, **4** and **6**. The Fe^2+^ was monitored by measuring the formation of Perl's Prussian blue at 700 nm. The method reported by Padmaja *et al.* \[[@R45]\] was used, with slight modification. Briefly, volumes of test solutions were mixed with 500 µL of phosphate buffer (pH 6.6) and 500 µL of 1% potassium ferricyanide and incubated at 50 °C for 20 min. Then 500 µL of 10% trichloroacetic acid was added to the mixture and centrifuged at 3000 rpm for 10 min. Supernatant (500 µL) was diluted with 500 µL of water and shaken with 100 µL of freshly prepared 0.1% ferric chloride. The absorbance was measured at 700 nm. Butylated hydroxytoluene (BHT) was used as a positive control. Increased absorbance of the reaction mixture indicates higher reduction capacity of the compounds.

ANTIOXIDANT ASSAY
=================

DPPH Free radical Scavenging Assay
----------------------------------

The free radical scavenging activity of compounds **3**, **4** and **6** was evaluated according to described methods \[[@R39]\]. Briefly, the test samples, prior dissolved in DMSO (SIGMA) beforehand, were mixed with a 20 mg/l 2,2-diphenyl-1-picryl-hydrazyl (DPPH) methanol solution, to give final concentrations of 1, 10, 25, 50, 75, 100, and 200 µg/mL. After 30 min at room temperature, the absorbance values were measured at 517 nm and converted into percentage of antioxidant activity. L-ascorbic acid was used as a standard control. The percentage of decolouration of DPPH (%) was calculated as follows:

$$\operatorname{\%~}\mathit{decolouration}~\mathit{of}~\mathit{DPPH}\operatorname{~=}\frac{(\mathit{Absorbance}~\mathit{of}~\mathit{control}\operatorname{~-~}\mathit{Absorbance}~\mathit{of}~\mathit{test}~\mathit{sample}\operatorname{)~}x~100}{\mathit{Absorbance}~\mathit{of}~\mathit{control}}$$

The radical scavenging percentages were plotted against the logarithmic values of the concentration of test samples and a linear regression curve was established in order to calculate the EC~50~ (µg/ml), which is the amount of sample necessary to inhibit by 50% the absorbance of free radical DPPH. All the analyses were carried out in triplicate.

Statistical Analysis
--------------------

Data were analyzed by one-way analysis of variance followed by Waller-Duncan Post Hoc test. The experimental results were expressed as the mean ± Standard Deviation (SD). Differences between groups were considered significant when *p* \< 0.05. All analyses were performed using the Statistical Package for Social Sciences (SPSS, version 12.0) software.

CONCLUSION
==========

The findings described in the present work have confirmed the synthetic potential of 2-aminothiophenes and the very high reactivity of the title diazonium salt **5.** In addition to the normally anticipated coupling products described the previous investigations, this reactions' intermediate further reacts with itself to give the homocoupling product **6.** Compounds **6** and **4** were respectively the most active compounds against bacteria (MIC = 32-64 μg/ml) and yeasts (MIC = 16--64 μg/ml). Compound **6** also showed high radical-scavenging activity and ferric reducing power when compared with vitamin C and BHT used as reference antioxidants suggesting that this compound could be used as a tool for the design of novel antioxidant derivatives.
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###### 

HSQC and HMBC interactions and ^1^H and ^13^C chemical shifts δ in compound **6** in DMSO-d~6~ as the solvent (25 °C).

  C-atom          δ ^13^C   HSQC (H→C)                HMBC (H→C)
  --------------- --------- ------------------------- -------------------------------------------------------------------------
  6, 20 and 34    119.9                               7.51 (H-8, H-22, H-36)
  14, 28 and 42   153.5                               
  1, 15 and 29    147.8                               
  13, 27 and 41   184.9                               
  11, 25 and 39   154.9                               8.73 (H-7, H-21, H-35), 7.85 (H-9, H-23, H-37), 7.53 (H-10, H-24, H-38)
  10, 24 and 38   117.1     7.53 (H-10, H-24, H-38)   7.51 (H-8, H-22, H-36)
  9, 23 and 37    135.5     7.85 (H-9, H-23, H-37)    8.73 (H-7, H-21, H-35)
  8, 22 and 36    125.4     7.51 (H-8, H-22, H-36)    7.53 (H-10, H-24, H-38)
  7, 21 and 35    128.9     8.73 (H-7, H-21, H-35)    7.85 (H-9, H-23, H-37)
  4, 18 and 32    114.9                               
  5, 19 and 33    153.7                               

###### 

Antimicrobial activity (MIC and MMC in µg/mL) of compounds **4** and **6** against bacterial and yeast species.

  ------------------ --------------------------- -------- -------- -------- -------- -------- --------- --------- --------- -------- -------- --------
  **Compounds**      **Inhibition Parameters**   **ST**   **SF**   **EF**   **KP**   **EC**   **STB**   **STA**   **CPn**   **CP**   **CA**   **CG**
  **6**              MIC                         64       32       64       32       32       64        32        64        64       32       128
  MMC                64                          32       64       64       32       64       64        64        64        64       128      
  MMC/MIC            1                           1        1        2        1        1        2         1         1         2        1        
  **4**              MIC                         \>256    32       \>256    \>256    64       \>256     64        32        32       16       64
  MMC                nd                          64       nd       nd       64       nd       64        64        32        32       64       
  MMC/MIC            nd                          2        nd       nd       1        nd       1         2         1         2        1        
  \*Standard drugs   MIC                         8        2        2        2        8        8         1         4         2        4        2
  MMC                8                           4        4        4        8        8        2         4         8         4        4        
  MMC/MIC            1                           2        2        2        1        1        2         1         4         1        2        
  ------------------ --------------------------- -------- -------- -------- -------- -------- --------- --------- --------- -------- -------- --------

Compound **3** was not active at concentrations up to 256 μg/ml; nd: not determined; \* ciprofloxacin and nystatin were used as standard drugs for bacteria and yeasts respectively; MIC: Minimum inhibitory concentration; MMC: minimum microbicidal concentration; ST: *Salmonella typhi* ATCC6539; SF: *Shigella flexneri* ; EF: *Enterococcus faecalis* ATCC10541; KP: *Klebsiella pneumoniae* ATCC13883; EC: *Escherichia coli* ATCC11775; STB: *Salmonella paratyphi* B; STA: *Salmonella paratyphi* A ; CPn: *Candida parapsilosis*; CP: *Candida parapsilosis ATCC 22019*; CA: *Candida albicans* ATCC 9002; CG: *Candida glabrata* IP35.
